ASCO 2015 Highlights

After adjusting for sociodemographic characteristics, the percentage of patients with dual or Medicaid-only coverage increased from 16.84% to 18.09% in expansion states and dropped from 14.14% to 12.62% in nonexpansion states

Artificial intelligence holds promise for detecting lung cancer if research presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer is any indicator.

Patients diagnosed with stage IV lung cancer displayed higher proportions of EGFR mutations compared to those without.

Much progress has been made in the past 50 years since the signing of the National Cancer Act of 1971, which included the establishment of the President’s Cancer Panel. Nevertheless, there remain significant opportunities to make improvements across the cancer spectrum, perhaps none more pressing than in the realm of prevention and early detection.

An infusion of $95 million in Series C capital raise should enable a leading value cancer-care enabler to expand into new markets, invest in its existing oncology and health plan partnerships, and deepen its clinical value-based care model, according to a recently released press statement from Thyme Care.